Clinical Trials Browser

Recurrence × abemaciclib × 30 days × Clear all

NCT07209449 2026-05-22

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Phase 2 Recruiting

Recurrence, Endometrial Neoplasms

NCT06760637 2026-05-19

FourLight-3

Phase 3 Active not recruiting

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence